Influence of β-lactam pharmacodynamics on the systems microbiology of gram-positive and gram-negative polymicrobial communities
ObjectivesWe sought to evaluate the pharmacodynamics of β-lactam antibacterials against polymicrobial communities of clinically relevant gram-positive and gram-negative pathogens.MethodsTwo Enterococcus faecalis isolates, two Staphylococcus aureus isolates, and three Escherichia coli isolates with v...
Saved in:
Main Authors: | Nicholas M. Smith (Author), Harpreet Kaur (Author), Ravneet Kaur (Author), Trisha Minoza (Author), Michael Kent (Author), Ayeh Barekat (Author), Justin R. Lenhard (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetic/Pharmacodynamic Adequacy of Novel β-Lactam/β-Lactamase Inhibitors against Gram-Negative Bacterial in Critically Ill Patients
by: Ruiying Han, et al.
Published: (2021) -
Infectious disease: how to manage Gram-positive and Gram-negative pathogen conundrums with dual beta-lactam therapy
by: Alireza FakhriRavari, et al.
Published: (2022) -
Microbiological, Clinical, and PK/PD Features of the New Anti-Gram-Negative Antibiotics: β-Lactam/β-Lactamase Inhibitors in Combination and Cefiderocol-An All-Inclusive Guide for Clinicians
by: Luigi Principe, et al.
Published: (2022) -
The prevalence of gram-negative bacteria with difficult-to-treat resistance and utilization of novel β-lactam antibiotics in the southeastern United States
by: Y. Vivian Tsai, et al.
Published: (2024) -
Impact of Beta-Lactam Target Attainment on Resistance Development in Patients with Gram-Negative Infections
by: Nicole F. Maranchick, et al.
Published: (2023)